Fidelity Advisor Biotechnology Fund - Class C
FBTCX
NASDAQ
| Weiss Ratings | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Eirene Kontopoulos (8) | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Advisor Biotechnology Fund - Class C | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 27, 2000 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.03% | |||
| Dividend | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.74% | |||
| Asset Allocation | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.15% | |||
| Stock | 97.25% | |||
| U.S. Stock | 92.44% | |||
| Non-U.S. Stock | 4.81% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 2.60% | |||
| Price History | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.54% | |||
| 30-Day Total Return | -8.69% | |||
| 60-Day Total Return | 5.07% | |||
| 90-Day Total Return | 19.48% | |||
| Year to Date Total Return | 26.88% | |||
| 1-Year Total Return | 54.35% | |||
| 2-Year Total Return | 47.22% | |||
| 3-Year Total Return | 108.99% | |||
| 5-Year Total Return | 72.26% | |||
| Price | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $36.44 | |||
| 1-Month High NAV | $39.90 | |||
| 52-Week Low NAV | $23.99 | |||
| 52-Week Low NAV (Date) | Sep 19, 2025 | |||
| 52-Week High NAV | $39.90 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.59 | |||
| Standard Deviation | 22.02 | |||
| Balance Sheet | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 2.43B | |||
| Operating Ratios | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.71% | |||
| Turnover Ratio | 51.00% | |||
| Performance | FBTCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 50.09% | |||
| Last Bear Market Total Return | -14.17% | |||